177 related articles for article (PubMed ID: 37259331)
21. Oligosaccharide structure of a functional unit RvH1-b of Rapana venosa hemocyanin using HPLC/electrospray ionization mass spectrometry.
Beck A; Hillen N; Dolashki A; Stevanovic S; Salvato B; Voelter W; Dolashka-Angelova P
Biochimie; 2007 Aug; 89(8):938-49. PubMed ID: 17400357
[TBL] [Abstract][Full Text] [Related]
22. GC-MS based comparative metabolomic analysis of MCF-7 and MDA-MB-231 cancer cells treated with Tamoxifen and/or Paclitaxel.
Semreen MH; Alniss H; Cacciatore S; El-Awady R; Mousa M; Almehdi AM; El-Huneidi W; Zerbini L; Soares NC
J Proteomics; 2020 Aug; 225():103875. PubMed ID: 32534214
[TBL] [Abstract][Full Text] [Related]
23. Purification, Characterization, and Three-Dimensional Structure Prediction of Paramyosin, a Novel Allergen of
Yu C; Gao X; Lin H; Xu L; Ahmed I; Khan MU; Xu M; Chen Y; Li Z
J Agric Food Chem; 2020 Dec; 68(49):14632-14642. PubMed ID: 33175512
[TBL] [Abstract][Full Text] [Related]
24. Tamoxifen induces apoptosis through cancerous inhibitor of protein phosphatase 2A-dependent phospho-Akt inactivation in estrogen receptor-negative human breast cancer cells.
Liu CY; Hung MH; Wang DS; Chu PY; Su JC; Teng TH; Huang CT; Chao TT; Wang CY; Shiau CW; Tseng LM; Chen KF
Breast Cancer Res; 2014 Sep; 16(5):431. PubMed ID: 25228280
[TBL] [Abstract][Full Text] [Related]
25. A synergistic antiproliferation effect of curcumin and docosahexaenoic acid in SK-BR-3 breast cancer cells: unique signaling not explained by the effects of either compound alone.
Altenburg JD; Bieberich AA; Terry C; Harvey KA; Vanhorn JF; Xu Z; Jo Davisson V; Siddiqui RA
BMC Cancer; 2011 Apr; 11():149. PubMed ID: 21510869
[TBL] [Abstract][Full Text] [Related]
26. Phenoloxidase activity of intact and chemically modified functional unit RvH1: a from molluscan Rapana venosa hemocyanin.
Dolashki A; Voelter W; Dolashka P
Comp Biochem Physiol B Biochem Mol Biol; 2011 Sep; 160(1):1-7. PubMed ID: 21536147
[TBL] [Abstract][Full Text] [Related]
27. Chemical Characterization,
Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N
Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087
[TBL] [Abstract][Full Text] [Related]
28. Suppression of Tumor Growth and Cell Migration by Indole-Based Benzenesulfonamides and Their Synergistic Effects in Combination with Doxorubicin.
Nguyen PL; Elkamhawy A; Choi YH; Lee CH; Lee K; Cho J
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077298
[TBL] [Abstract][Full Text] [Related]
29. Antitumor activity of a novel antiestrogen (Analog II) on human breast cancer cells.
Jain PT; Rajah TT; Pento JT
Anticancer Drugs; 1997 Nov; 8(10):964-73. PubMed ID: 9436640
[TBL] [Abstract][Full Text] [Related]
30. ErbB3 expression predicts sensitivity to elisidepsin treatment: in vitro synergism with cisplatin, paclitaxel and gemcitabine in lung, breast and colon cancer cell lines.
Teixidó C; Arguelaguet E; Pons B; Aracil M; Jimeno J; Somoza R; Marés R; Ramón Y Cajal S; Hernández-Losa J
Int J Oncol; 2012 Jul; 41(1):317-24. PubMed ID: 22485250
[TBL] [Abstract][Full Text] [Related]
31. Antibody-drug nanoparticle induces synergistic treatment efficacies in HER2 positive breast cancer cells.
Abedin MR; Powers K; Aiardo R; Barua D; Barua S
Sci Rep; 2021 Apr; 11(1):7347. PubMed ID: 33795712
[TBL] [Abstract][Full Text] [Related]
32. Methylglyoxal at metronomic doses sensitizes breast cancer cells to doxorubicin and cisplatin causing synergistic induction of programmed cell death and inhibition of stemness.
Roy A; Sarker S; Upadhyay P; Pal A; Adhikary A; Jana K; Ray M
Biochem Pharmacol; 2018 Oct; 156():322-339. PubMed ID: 30170097
[TBL] [Abstract][Full Text] [Related]
33. Low-resolution structure of the proteolytic fragments of the Rapana venosa hemocyanin in solution.
Dainese E; Svergun D; Beltramini M; Di Muro P; Salvato B
Arch Biochem Biophys; 2000 Jan; 373(1):154-62. PubMed ID: 10620334
[TBL] [Abstract][Full Text] [Related]
34. The Anti-Breast Cancer Potential of Bis-Isatin Scaffolds.
Guo H; Diao QP
Curr Top Med Chem; 2020; 20(16):1499-1503. PubMed ID: 32156238
[TBL] [Abstract][Full Text] [Related]
35. Protein expression of G-protein inwardly rectifying potassium channels (GIRK) in breast cancer cells.
Dhar MS; Plummer HK
BMC Physiol; 2006 Aug; 6():8. PubMed ID: 16945134
[TBL] [Abstract][Full Text] [Related]
36. Changes in the gene expression profile of the bladder cancer cell lines after treatment with Helix lucorum and Rapana venosa hemocyanin.
Antonova O; Yossifova L; Staneva R; Stevanovic S; Dolashka P; Toncheva D
J BUON; 2015; 20(1):180-7. PubMed ID: 25778314
[TBL] [Abstract][Full Text] [Related]
37. Antitumor evaluation and 3D-QSAR studies of a new series of the spiropyrroloquinoline isoindolinone/aza-isoindolinone derivatives by comparative molecular field analysis (CoMFA).
Sadeghzadeh M; Salahinejad M; Zarezadeh N; Ghandi M; Baghery MK
Mol Divers; 2017 Nov; 21(4):821-830. PubMed ID: 28836075
[TBL] [Abstract][Full Text] [Related]
38. Antitumor activity of arsenite in combination with tetrandrine against human breast cancer cell line MDA-MB-231 in vitro and in vivo.
Yuan B; Yao M; Wang X; Sato A; Okazaki A; Komuro H; Hayashi H; Toyoda H; Pei X; Hu X; Hirano T; Takagi N
Cancer Cell Int; 2018; 18():113. PubMed ID: 30123091
[TBL] [Abstract][Full Text] [Related]
39. The quinoxaline di-N-oxide DCQ blocks breast cancer metastasis in vitro and in vivo by targeting the hypoxia inducible factor-1 pathway.
Ghattass K; El-Sitt S; Zibara K; Rayes S; Haddadin MJ; El-Sabban M; Gali-Muhtasib H
Mol Cancer; 2014 Jan; 13():12. PubMed ID: 24461075
[TBL] [Abstract][Full Text] [Related]
40. Isolation and identification of novel selective antitumor constituents, sidrin and sidroside, from
Mostafa MAH; Khojah HMJ; Ohta T
Saudi Pharm J; 2023 Jun; 31(6):1019-1028. PubMed ID: 37234346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
